Loading…
← CockpitCompetitor Analysis › 7747.T Asahi Intecc Co., Ltd.Open in the cockpit ↗

Asahi Intecc Co., Ltd.7747.TCompetitor analysis, valuation and peers

Japan · JPY·Health Care›Medical Specialties

Makes guidewires and catheters used in cardiovascular and other minimally invasive medical procedures.

≈ A specialized medical-device maker like a smaller Boston Scientific supplierMomentum leader 92
Mkt cap
$7.09B
US dollars, full cap
Free float
82%
of shares outstanding
$/day
$34.8M
20-day average traded
Fwd P/E
29.7×
forward earnings
ROIC−WACC
+18.0 pp
WACC 8.7%
Hurdle
-4 pp
Req g minus delivered
Next earnings
86 days
12 Feb 2027
Close · JPY¥4,225
1D-0.8%
1W+11.0%
1M+21.6%
3M+9.1%
6M+24.5%
YTD+43.8%
1Y+72.0%
ATR %3.4%
52w lowhigh2.4% off high

What Asahi Intecc does

Makes guidewires and catheters used in cardiovascular and other minimally invasive medical procedures.

Sells guidewires and catheters both under its own Asahi brand and as components to larger device makers who sell them under their names, so some sales depend on those partners' volumes. Revenue rests on the number of procedures where a guidewire is used.

In one line: A specialized medical-device maker like a smaller Boston Scientific supplier.

Products and services

  • Cardiovascular guidewires
  • Catheters
  • Peripheral/neurovascular devices

Customers

  • Hospitals/cath labs worldwide
  • Medical device OEM partners

Where it sits in the supply chain

  • Medical devices
  • Interventional device manufacturing
  • Guidewires + catheters

What could go right

  • Minimally invasive procedure volume growth

What could go wrong

  • Hospital procedure volume cyclicality

Moat: narrow (process know-how, IP / patents). Precision wire-forming know-how for ultra-thin guidewires is difficult to replicate.

Headquarters: Nagoya, Japan · Founded: 1972 · Employees: 10,177

Named competitors

Asahi Intecc at a glance

Size Asahi Intecc (7747.T) is a Japan Health Care company (Medical Specialties) with a market value of $7.09B, the 187th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥4,225 on 18 Nov 2026.

Performance Over six months the shares gained 24.5%, against +30.9% for the median peer and -1.4% for the Japan market (cap-weighted) — 8th lowest of 21 in its peer set.

Growth Revenue grew 22.6% over the last twelve months (peer median +5.4%); the operating margin is 32.4% (peer median 15.7%).

Valuation It trades at 29.7× forward earnings against a peer median of 20.9× (5th most expensive of 21).

Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is -4 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 18.0 points above its cost of capital (8.7% WACC).

Next results Next results expected around 12 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026Peer median 1327747.T 119
Six months, rebased to 100: Asahi Intecc against the median of its 20 peers (local-currency closes).

Asahi Intecc financials

Reported figures in JPY; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue¥153B¥145B¥120B¥108B¥90.1B
Revenue growth—+21%+12%+19%—
Gross profit¥109B¥99.4B¥78.2B¥66.1B¥56.3B
EBITDA¥58.4B¥54.0B¥40.2B¥31.9B¥26.7B
Net income¥35.6B¥32.1B¥12.7B¥15.8B¥13.1B
Free cash flown/a¥31.7B¥32.4B¥24.8B¥6.85B
Capital expendituren/a¥8.93B¥8.58B¥10.5B¥12.7B
Total debt¥6.04B¥9.13B¥11.5B¥8.59B¥16.2B

Quarterly statements and history in the cockpit →

Asahi Intecc competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+20%+40%+60%0%+10%+20%YPSNBLCOCTECGETI-BCOH300832LNTHTFX68697701688617HAEGMEDLIVNBRKRPODDMMSIBIOQGENDEMANT7747.T6-month return →1-month return →
Up and to the right = strong over both horizons. Asahi Intecc is the large dot.

Fundamentals: revenue growth against valuation

-10%0%+10%+20%20×30×YPSNBLCOCTECGETI-BCOH300832LNTHTFX68697701688617HAEGMEDLIVNBRKRPODDMMSIBIODEMANT7747.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Asahi Intecc is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%BLCOCTECGETI-BCOH300832LNTHTFX68697701688617GMEDLIVNBRKRPODDBIOQGENDEMANT7747.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Asahi Intecc is the large dot.

Asahi Intecc competitors and peer comparison

Head to head with its named competitors (7747.T vs BSX vs MDT vs 4543.T)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Asahi Intecc 7747.T$7.09B+24%+23%32%29.7×15.1%
Boston Scientific BSX$63.3B-23%+9%21%14.1×5.8%
Medtronic MDT$129B+30%+10%20%16.8×9.1%
Terumo 4543.T$24.0B+32%+15%17%27.8×8.8%

How Asahi Intecc compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Asahi Intecc against its 20 peers (data as of 18 Nov 2026)
Measure7747.TPeer medianRank in peer set
1-month return+21.6%+8.5%3rd highest of 21
6-month return+24.5%+30.9%8th lowest of 21
Distance from 52-week high-2.4%-7.2%7th highest of 21
Revenue growth (TTM)+22.6%+5.4%3rd highest of 21
Operating margin32.4%15.7%3rd highest of 21
Forward P/E29.7×20.9×5th most expensive of 21
Growth the price implies (Req g, 7 yrs)15.1%10.6%6th most demanding of 20
Growth delivered (Del g)+18.8%+9.5%5th highest of 20
Hurdle (Req g minus delivered)-3.6 pp+2.0 pp8th least demanding of 20
ROIC minus cost of capital+18.0 pp+2.8 pp3rd highest of 21
EV / EBITDA18.6×15.2×6th most expensive of 19
Net debt / EBITDA-0.8×0.9×least indebted of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Asahi Intecc 7747.TJapan$7.09B+24%+23%32%29.7×15.1%+18.8%
Ypsomed YPSN.SWSwitzerland$6.83B+27%-13%30%31.7×n/an/a
Bausch + Lomb BLCO.TOCanada$7.41B+35%+11%9%18.3×12.0%+10.0%
ConvaTec CTEC.LUnited Kingdom$6.78B+37%+2%16%17.7×17.2%+4.6%
Getinge GETI-B.STSweden$7.45B+40%-4%14%21.1×5.0%+3.2%
Cochlear COH.AXAustralia$6.72B+58%-1%13%29.1×23.9%+9.3%
Shenzhen New Industries Biomedical Engineering 300832.SZChina$7.50B+21%+7%43%26.9×2.9%+15.7%
Lantheus LNTHUnited States$6.67B+6%+2%19%15.5×0.4%+35.3%
Teleflex TFXUnited States$6.58B+23%-29%12%16.7×16.5%-4.7%
Sysmex 6869.TJapan$8.06B+58%+8%13%32.0×4.4%+10.4%
Shimadzu 7701.TJapan$8.14B+24%+8%14%21.0×8.3%+7.3%
APT Medical 688617.SSChina$6.06B+23%+28%37%38.6×9.0%+40.1%
Haemonetics HAEUnited States$5.59B+106%+4%19%20.7×10.9%+8.9%
Globus Medical GMEDUnited States$9.34B-16%+13%23%13.7×4.6%+30.1%
LivaNova LIVNUnited States$5.21B+28%+12%15%20.9×14.2%+8.2%
Bruker BRKRUnited States$9.66B+43%+2%10%27.0×25.4%+11.6%
Insulet PODDUnited States$9.71B-11%+26%18%18.6×10.6%+24.5%
Merit Medical Systems MMSIUnited States$5.15B+33%+9%14%19.1×12.6%+9.5%
Bio-Rad Laboratories BIOUnited States$10.1B+29%+1%9%34.6×26.0%+0.3%
Qiagen QGENUnited States$10.2B+41%+2%25%19.5×8.6%+2.2%
Demant A/S DEMANT.CODenmark$10.4B+39%+10%18%23.2×5.8%+9.8%

Questions

Who are Asahi Intecc's main competitors?
Named competitors: Boston Scientific (BSX), Medtronic (MDT), Terumo (4543.T). The cockpit's measured peer set (industry) also includes Ypsomed (YPSN.SW), Bausch + Lomb (BLCO.TO), ConvaTec (CTEC.L), Getinge (GETI-B.ST), Cochlear (COH.AX), Shenzhen New Industries Biomedical Engineering (300832.SZ).
Is Asahi Intecc expensive compared with its peers?
On forward p/e it trades at 29.7× against a peer median of 20.9×, 5th most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is -4 pp: the price already allows for a slowdown.
How has Asahi Intecc stock performed?
Over six months to 18 Nov 2026 the shares returned +24.5% against +30.9% for the median peer; over one year +72.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.